Historical record - last NADAC effective date: 7/17/2024
Product Information
LEFLUNOMIDE 20 MG TABLET is a generic product labeled by Apotex Corp., priced at $0.3368 per EA under NDC 60505250303. Its NADAC has been published 560 times since Nov 28, 2013.
FDA first approved this application on Sep 13, 2005. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
20 mg/1
Manufacturer
Apotex Corp.NDC
60505250303
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
7/17/2024
Active Ingredients
LEFLUNOMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA077090FDA Approved
9/13/2005
TE Code
AB
On Market Since
9/13/2005
Pharmacological Classes
Price Statistics
The NADAC for LEFLUNOMIDE 20 MG TABLET has been published 560 times since Nov 28, 2013, and over the history we have for it it has declined 20.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3368 per EA |
|---|---|
| All-time high | $5.0165 (Jan 13, 2016) |
| All-time low | $0.3154 (Apr 19, 2023) |
| Median price | $1.1440 |
| Average price | $1.5959 |
| Largest weekly change | +193.5% (Jul 22, 2015) |
| Weeks tracked | 560 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
-12.1%
5Y
-59.9%
All
-20.1%
Last surveyed Aug 14, 2024 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 13% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Apotex Corp. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
LEFLUNOMIDE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Antirheumatic Agent class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of LEFLUNOMIDE 20 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LEFLUNOMIDE 20 MG TABLET, manufactured by Apotex Corp., is $0.3368 per EA (NDC 60505250303), effective Aug 14, 2024.
How has the price of LEFLUNOMIDE 20 MG TABLET changed over time?
Over the history we have for it, the NADAC for LEFLUNOMIDE 20 MG TABLET has declined 20.1%. It has been tracked across 560 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for LEFLUNOMIDE 20 MG TABLET?
Since Nov 28, 2013, the NADAC for LEFLUNOMIDE 20 MG TABLET has ranged from a low of $0.3154 (Apr 19, 2023) to a high of $5.0165 (Jan 13, 2016), with a median of $1.1440 per EA.
Are there cheaper alternatives to LEFLUNOMIDE 20 MG TABLET?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LEFLUNOMIDE 20 MG TABLET, is $0.2944 per EA — about 13% below LEFLUNOMIDE 20 MG TABLET.
Who manufactures LEFLUNOMIDE 20 MG TABLET?
LEFLUNOMIDE 20 MG TABLET (NDC 60505250303) is labeled by Apotex Corp., and CMS classifies it as a generic product.